Bristol Myers Squibb (NYSE: BMY) strengthens Camzyos growth case with positive adolescent SCOUT-HCM data
Read More Pharma Industry News Amarin bags Vascepa FDA approval for reducing cardiovascular risk Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA)… bypharmanewsdailyDecember 16, 2019
